2023
DOI: 10.3390/clinpract13050104
|View full text |Cite
|
Sign up to set email alerts
|

AI-Powered Renal Diet Support: Performance of ChatGPT, Bard AI, and Bing Chat

Ahmad Qarajeh,
Supawit Tangpanithandee,
Charat Thongprayoon
et al.

Abstract: Patients with chronic kidney disease (CKD) necessitate specialized renal diets to prevent complications such as hyperkalemia and hyperphosphatemia. A comprehensive assessment of food components is pivotal, yet burdensome for healthcare providers. With evolving artificial intelligence (AI) technology, models such as ChatGPT, Bard AI, and Bing Chat can be instrumental in educating patients and assisting professionals. To gauge the efficacy of different AI models in discerning potassium and phosphorus content in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
21
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 34 publications
(21 citation statements)
references
References 45 publications
0
21
0
Order By: Relevance
“…The authors were primarily affiliated with institutions in the United States (n=47 of 122 different countries identified per publication, 38.5%), followed by Germany (n=11/122, 9%), Turkey (n=7/122, 5.7%), the United Kingdom (n=6/122, 4.9%), China/Australia/Italy (n=5/122, 4.1%, respectively), and 24 (n=36/122, 29.5%) other countries. Most studies examined one or more applications based on the GPT-3.5 architecture (n=66 of 124 different LLMs examined per study, 53.2%) 13,2629,3134,3640,4249,5254,5661,63,6567,71,72,74,75,77,78,8189,91,92,94,95,97100,102–104,106109,111 , followed by GPT-4 (n=33/124, 26.6%) 13,25,27,29,30,3436,41,43,50,51,54,55,58,61,64,6870,74,76,7981,83,87,89,90,93,96,98,99,101,105 , Bard (n=10/124, 8.1%; now known as Gemini) 33,48,49,55,73,74,80,87,94,99 , Bing Chat (n=7/124, 5.7%; now Microsoft Copilot) 49,51,55,73,94,99,110 , and other applications based on Bidirectional Encoder Representations from Transformers (BERT; n=4/124, 3...…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…The authors were primarily affiliated with institutions in the United States (n=47 of 122 different countries identified per publication, 38.5%), followed by Germany (n=11/122, 9%), Turkey (n=7/122, 5.7%), the United Kingdom (n=6/122, 4.9%), China/Australia/Italy (n=5/122, 4.1%, respectively), and 24 (n=36/122, 29.5%) other countries. Most studies examined one or more applications based on the GPT-3.5 architecture (n=66 of 124 different LLMs examined per study, 53.2%) 13,2629,3134,3640,4249,5254,5661,63,6567,71,72,74,75,77,78,8189,91,92,94,95,97100,102–104,106109,111 , followed by GPT-4 (n=33/124, 26.6%) 13,25,27,29,30,3436,41,43,50,51,54,55,58,61,64,6870,74,76,7981,83,87,89,90,93,96,98,99,101,105 , Bard (n=10/124, 8.1%; now known as Gemini) 33,48,49,55,73,74,80,87,94,99 , Bing Chat (n=7/124, 5.7%; now Microsoft Copilot) 49,51,55,73,94,99,110 , and other applications based on Bidirectional Encoder Representations from Transformers (BERT; n=4/124, 3...…”
Section: Resultsmentioning
confidence: 99%
“…Most studies examined one or more applications based on the GPT-3.5 architecture (n=66 of 124 different LLMs examined per study, 53.2%) 13,2629,3134,3640,4249,5254,5661,63,6567,71,72,74,75,77,78,8189,91,92,94,95,97100,102–104,106109,111 , followed by GPT-4 (n=33/124, 26.6%) 13,25,27,29,30,3436,41,43,50,51,54,55,58,61,64,6870,74,76,7981,83,87,89,90,93,96,98,99,101,105 , Bard (n=10/124, 8.1%; now known as Gemini) 33,48,49,55,73,74,80,87,94,99 , Bing Chat (n=7/124, 5.7%; now Microsoft Copilot) 49,51,55,73,94,99,110 , and other applications based on Bidirectional Encoder Representations from Transformers (BERT; n=4/124, 3.2%) 13,83,84 , Large Language Model Meta-AI (LLaMA; n=3/124, 2.4%) 55 , or Claude by Anthropic (n=1/124, 0.8%) 55 . The majority of applications were p...…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Current research has started to compare the performance of AI chatbots within medical subspecialties by assessing chatbot accuracy and highlighting opportunities for improvement. Chatbot utility is being explored as a strategy to aid physicians in tasks such as designing comprehensive diets for patients with chronic kidney disease, 5 serving as an adjunct in radiologic decision‐making, 6 and triaging ophthalmic conditions 7 . Chatbot performance is also being explored in aiding patients with frequently asked questions 8,9 about their cancer diagnosis, 10 or recent plastic surgery 11 .…”
Section: Introductionmentioning
confidence: 99%